Greatwall kinase at a glance

Anna Castro1, Thierry Lorca1

  • 1Centre de Recherche de Biologie cellulaire de Montpellier (CRBM), CNRS UMR 5237, Université de Montpellier, 1919 Route de Mende, 34293 Montpellier cedex 5, France Thierry.lorca@crbm.cnrs.fr anna.castro@crbm.cnrs.fr.

Journal of Cell Science
|October 26, 2018
PubMed

Insights

The Greatwall (Gwl) kinase pathway, through Arpp19 and ENSA proteins, inhibits PP2A-B55 phosphatase, ensuring proper cell division timing. This pathway is crucial for mitosis and is influenced by nutrients and cancer.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mitosis regulation involves a balance between kinase and phosphatase activities.
  • Cyclin-B-Cdk1 and PP2A-B55 are key regulators of mitotic progression.
  • The Greatwall (Gwl) kinase pathway modulates PP2A-B55 activity.

Purpose of the Study:

  • To elucidate the regulation of Gwl kinase in space and time.
  • To understand the role of the Gwl-Arpp19-ENSA-PP2A-B55 pathway in cell cycle control.
  • To explore Gwl's influence on oncogenic properties and nutrient deprivation.

Main Methods:

  • Review of existing literature and research findings.
  • Analysis of signaling pathways involved in mitosis.
  • Discussion of Gwl's regulatory mechanisms and cellular functions.

Main Results:

  • Gwl phosphorylates Arpp19 and ENSA, inhibiting PP2A-B55.
  • This inhibition is critical for the timely progression of M and S phases.
  • The Gwl pathway's activity is influenced by nutrient availability and cellular context.

Conclusions:

  • The Gwl-Arpp19-ENSA-PP2A-B55 pathway is essential for accurate cell division across species.
  • Gwl's modulation of this pathway impacts cell proliferation and oncogenesis.
  • Understanding Gwl regulation offers insights into cell cycle control and cancer therapeutics.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
534
Framing Effects03:26

Framing Effects

Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in...
8.0K